Agios Pharmaceuticals | AGIO - 销售毛利

股票价格
27.81
每天变化
-0.33 -1.16%
每月一次
-4.94%
每年
-15.00%
Q1 预测
27.01


金融业
股票价格
USD
资产
USD 1.3B
现金及等价物
USD 89.13M
销售成本
USD 1.88M
流动资产
USD 942.05M
流动负债
USD 82.21M
债务
USD 44.52M
EBIT
USD -121.58M
EBITDA
USD -115.5M
员工
486
EPS每股收益
USD -1.86
股本和储备
USD 1.19B
销售毛利
USD 18.09M
债务利息支出
USD 1.39B
利息收入
USD 13.37M
贷款资金
USD 1.06M
市值
USD 1.59B
净收入
USD -108.04M
营业费用
USD 141.55M
营业利润
USD -121.58M
普通股股本
USD 58.45M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 19.97M
销售和管理费用
USD 42.97M
股票
USD 32.92M
贸易债权人
USD 18.36M
应收帐款人
USD 10.58M


销售毛利 更改 日
AbbVie USD 10.47B 605M 2025-09
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
Arrowhead Research USD 256.47M 228.7M 2025-09
Astellas Pharma JPY 456.81B 38.02B 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Exelixis USD 572.18M 7M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Incyte USD 1.39B 118.68M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Merck USD 13.42B 431M 2025-09
Moderna USD 226M 583M 2025-12
Nektar Therapeutics USD 13.75M 650K 2024-06
Novartis USD 10.82B 695M 2025-09
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12